Biosynex S.A.
ALBIO.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €101,200 | €92,978 | €196,587 | €382,533 |
| % Growth | 8.8% | -52.7% | -48.6% | – |
| Cost of Goods Sold | €43,746 | €43,846 | €132,066 | €199,979 |
| Gross Profit | -€20,000 | €49,132 | €64,520 | €182,553 |
| % Margin | -19.8% | 52.8% | 32.8% | 47.7% |
| R&D Expenses | €0 | €3,918 | €2,853 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €36,061 | €34,200 | €38,607 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €93,754 | €46,557 | €26,390 | €27,153 |
| Operating Expenses | €93,754 | €86,536 | €63,443 | €65,760 |
| Operating Income | -€21,100 | -€37,404 | €38,864 | €140,654 |
| % Margin | -20.8% | -40.2% | 19.8% | 36.8% |
| Other Income/Exp. Net | -€17,169 | -€2,273 | -€14,699 | -€3,712 |
| Pre-Tax Income | -€38,428 | -€39,677 | €24,184 | €136,942 |
| Tax Expense | -€1,400 | -€2,555 | €8,571 | €32,937 |
| Net Income | -€43,300 | -€36,946 | €15,657 | €104,004 |
| % Margin | -42.8% | -39.7% | 8% | 27.2% |
| EPS | -3.32 | -2.85 | 1.26 | 8.32 |
| % Growth | -16.5% | -326.2% | -84.9% | – |
| EPS Diluted | -3.32 | -2.85 | 1.26 | 8.27 |
| Weighted Avg Shares Out | 13,030 | 12,967 | 10,253 | 10,318 |
| Weighted Avg Shares Out Dil | 13,030 | 12,967 | 10,272 | 10,390 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €563 | €886 | €58 |
| Interest Expense | €6,200 | €2,638 | €501 | €365 |
| Depreciation & Amortization | €5,374 | €24,619 | €16,368 | €6,613 |
| EBITDA | -€17,826 | -€10,184 | €46,730 | €146,598 |
| % Margin | -17.6% | -11% | 23.8% | 38.3% |